SE437766B - Forfarande for framstellning av en blandning av en antiinflammatorisk steroid och ett som drivemne anvendbart fluorkolvete - Google Patents

Forfarande for framstellning av en blandning av en antiinflammatorisk steroid och ett som drivemne anvendbart fluorkolvete

Info

Publication number
SE437766B
SE437766B SE8103143A SE8103143A SE437766B SE 437766 B SE437766 B SE 437766B SE 8103143 A SE8103143 A SE 8103143A SE 8103143 A SE8103143 A SE 8103143A SE 437766 B SE437766 B SE 437766B
Authority
SE
Sweden
Prior art keywords
propellant
steroid
mixture
process according
suspended
Prior art date
Application number
SE8103143A
Other languages
English (en)
Swedish (sv)
Other versions
SE8103143L (sv
Inventor
P T Tanskanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of SE8103143L publication Critical patent/SE8103143L/
Publication of SE437766B publication Critical patent/SE437766B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8103143A 1980-05-19 1981-05-19 Forfarande for framstellning av en blandning av en antiinflammatorisk steroid och ett som drivemne anvendbart fluorkolvete SE437766B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI801610A FI63672C (fi) 1980-05-19 1980-05-19 Foerfarande foer framstaellning av en blandning av beklometasondipropionat och triklorfluormetan eller diklordifluormetan

Publications (2)

Publication Number Publication Date
SE8103143L SE8103143L (sv) 1981-11-20
SE437766B true SE437766B (sv) 1985-03-18

Family

ID=8513487

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8103143A SE437766B (sv) 1980-05-19 1981-05-19 Forfarande for framstellning av en blandning av en antiinflammatorisk steroid och ett som drivemne anvendbart fluorkolvete

Country Status (21)

Country Link
US (1) US4347236A (ja)
JP (1) JPS5716820A (ja)
AT (1) AT380791B (ja)
BE (1) BE888822A (ja)
CA (1) CA1162852A (ja)
CH (1) CH647408A5 (ja)
CS (1) CS221831B2 (ja)
DD (1) DD158856A5 (ja)
DE (1) DE3119745A1 (ja)
DK (1) DK218481A (ja)
ES (1) ES8203606A1 (ja)
FI (1) FI63672C (ja)
FR (1) FR2482457A1 (ja)
GB (1) GB2076422B (ja)
HU (1) HU188093B (ja)
NL (1) NL8102457A (ja)
NO (1) NO155429C (ja)
PL (1) PL127872B1 (ja)
PT (1) PT72989B (ja)
SE (1) SE437766B (ja)
SU (1) SU1184428A3 (ja)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5674472A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Canisters containing aerosol formulations containing P134a and fluticasone propionate
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US6200549B1 (en) 1991-12-12 2001-03-13 Glaxo Group Limited Aerosol formulation containing P134a and particulate medicament
US6333023B1 (en) 1991-12-12 2001-12-25 Glaxo Group Limited Aerosol formulation containing particulate formoterol, propellant and polar cosolvent
US6743413B1 (en) 1991-12-18 2004-06-01 3M Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7994197B2 (en) 2007-02-11 2011-08-09 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US8080236B2 (en) 2002-04-17 2011-12-20 Nektar Therapeutics Uk, Ltd Particulate materials
US9394314B2 (en) 2012-12-21 2016-07-19 Map Pharmaceuticals, Inc. 8′-hydroxy-dihydroergotamine compounds and compositions

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
AU601176B2 (en) * 1986-03-10 1990-09-06 Kurt Burghart Benzodiazepine aerosols
JPH01156916A (ja) * 1987-09-25 1989-06-20 Ss Pharmaceut Co Ltd 肝疾患治療剤
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
MX9304585A (es) 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629985A (ja) * 1962-11-29
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
JPS531814A (en) * 1976-06-28 1978-01-10 Toshiba Corp Control unit of induction motor
US4225597A (en) * 1976-10-01 1980-09-30 Schering Corporation Beclomethasone dipropionate-hexane solvate and aerosols prepared therefrom
IT1121513B (it) * 1979-05-28 1986-04-02 Chiesi Farma Spa Processo per la conversione di umo steroide antiinfiammatorio in una forma suscettibile di essere somministarta come aerosol

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919069B2 (en) 1991-12-12 2005-07-19 Glaxo Group Limited Aerosol formulation containing particulate formoterol, propellant and polar cosolvent
US6333023B1 (en) 1991-12-12 2001-12-25 Glaxo Group Limited Aerosol formulation containing particulate formoterol, propellant and polar cosolvent
US5674472A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Canisters containing aerosol formulations containing P134a and fluticasone propionate
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US6200549B1 (en) 1991-12-12 2001-03-13 Glaxo Group Limited Aerosol formulation containing P134a and particulate medicament
US6238647B1 (en) 1991-12-12 2001-05-29 Glaxo Group Limited Aerosol formulations containing salmeterol xinafoate, an anticholinergic agent and tetrafluoroethane
US6251368B1 (en) 1991-12-12 2001-06-26 Glaxo Group Limited Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant
US6303103B1 (en) 1991-12-12 2001-10-16 Glaxo Group Limited Aerosols containing salmeterol xinafoate and an anticholinergic medicament
US6306369B1 (en) 1991-12-12 2001-10-23 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US6893628B2 (en) 1991-12-12 2005-05-17 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US7498020B2 (en) 1991-12-12 2009-03-03 Glaxo Group Limited Medicaments
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US6743413B1 (en) 1991-12-18 2004-06-01 3M Company Suspension aerosol formulations
US8080236B2 (en) 2002-04-17 2011-12-20 Nektar Therapeutics Uk, Ltd Particulate materials
US10251881B2 (en) 2002-04-17 2019-04-09 Nektar Therapeutics Particulate materials
US8828359B2 (en) 2002-04-17 2014-09-09 Nektar Therapeutics Particulate materials
US9616060B2 (en) 2002-04-17 2017-04-11 Nektar Therapeutics Particulate materials
US8470301B2 (en) 2002-04-17 2013-06-25 Nektar Therapeutics Particulate materials
US9833451B2 (en) 2007-02-11 2017-12-05 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US8119639B2 (en) 2007-02-11 2012-02-21 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US10172853B2 (en) 2007-02-11 2019-01-08 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US7994197B2 (en) 2007-02-11 2011-08-09 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US9394314B2 (en) 2012-12-21 2016-07-19 Map Pharmaceuticals, Inc. 8′-hydroxy-dihydroergotamine compounds and compositions

Also Published As

Publication number Publication date
ES502286A0 (es) 1982-04-01
NL8102457A (nl) 1981-12-16
FR2482457A1 (fr) 1981-11-20
GB2076422B (en) 1983-12-14
DD158856A5 (de) 1983-02-09
HU188093B (en) 1986-03-28
PL127872B1 (en) 1983-12-31
NO155429C (no) 1987-04-01
PT72989B (en) 1983-07-06
DK218481A (da) 1981-11-20
CS221831B2 (en) 1983-04-29
GB2076422A (en) 1981-12-02
AT380791B (de) 1986-07-10
FR2482457B1 (ja) 1985-01-04
SE8103143L (sv) 1981-11-20
PT72989A (en) 1981-06-01
SU1184428A3 (ru) 1985-10-07
NO811686L (no) 1981-11-20
NO155429B (no) 1986-12-22
ES8203606A1 (es) 1982-04-01
CH647408A5 (de) 1985-01-31
JPS5716820A (en) 1982-01-28
DE3119745A1 (de) 1982-02-11
ATA179181A (de) 1985-12-15
FI63672B (fi) 1983-04-29
FI801610A (fi) 1981-11-20
FI63672C (fi) 1983-08-10
US4347236A (en) 1982-08-31
CA1162852A (en) 1984-02-28
BE888822A (fr) 1981-11-16
PL231220A1 (ja) 1982-01-18

Similar Documents

Publication Publication Date Title
SE437766B (sv) Forfarande for framstellning av en blandning av en antiinflammatorisk steroid och ett som drivemne anvendbart fluorkolvete
AU587010B2 (en) Physically modified beclomethasone dipropionate suitable for use in aerosols
IL42038A (en) Antiinflammatory steroids in the form of crystalline solvates and aerosol formulations containing them
JP5149199B2 (ja) メソトリオンの結晶化方法
JPH05208943A (ja) Ｎ−（トランス−４−イソプロピルシクロヘキシルカルボニル）−ｄ−フェニルアラニンの結晶及びその製造法
DK173555B1 (da) Fremgangsmåde til fremstilling af en ren polymorf form af terfenadin
EP0039369B1 (en) Beclomethasone ester solvates, process for their preparation, and preparation of a formulation
JP2018133227A (ja) 硫化物固体電解質の製造方法
EP0172672B1 (en) Preparation and use of new solvates of beclomethasone 17,21-diproprionate
US3838194A (en) Process for making hexagonal macrocrystals of aluminum hydride
CA1087958A (en) Process for the preparation of concentrated suspensions
BG97767A (bg) Бензендиметанол,подходящ за микронизиране
CN108586281B (zh) 一种氯化三甲基胺乙酰肼的制备方法
US3159673A (en) Separation of 2, 3, 6-trichlorobenzoic acid from a mixture of trichlorobenzoic acids
FI67299B (fi) Foerfarande foer framstaellning av ett alkansolvat av beklometasondipropionat
CA2888904A1 (en) Method for enlarging the particle size of crystalline microparticles of active substance
US20080096970A1 (en) Stable Nateglinide Form B Compositions
CN113476646A (zh) 一种用于德莫林皮肤敷料的复合抛射体系
NO180676B (no) 1-hydroksy-2-naftalenkarboksylat(hydroksynaftoat)-salt av 4-hydroksy-<alfa>1 £££6-(4-fenylbutoksy)-heksyl|amino|metyl|-1,3-benzendimetanol og fremgangsmåte for fremstilling derav
JPS62168539A (ja) カプセルの製法
Subrahmanya et al. The effect of wetting agents on the adsorption of crystal violet by glass
SE438334B (sv) Stabil koncentrerad losning av glycidyltrimetylammoniumklorid samt metod for framstellning av sadana losningar
Thomson 93. Solvent effect in dielectric polarisation. Part III. The behaviour of ethyl alcohol in certain ethers
Bennett et al. CCXXV.—Studies in the penthian series. Part IV. The four stereoisomeric oxides of benzamidobenzpenthiene
JPS58206679A (ja) チオエ−テル系酸化防止剤の球状製品の製造法

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8103143-7

Effective date: 19900518

Format of ref document f/p: F